This trial hasn't finished yet, there is still more patients to be dosed. Once the full number have been dosed and the final data readout provided, we may get some support or fast tracking. But I dare say some sort of phase 3 trial that expands the scope, numbers and checks for things like contraindications etc would still be required.
This trial hasn't finished yet, there is still more patients to...
Add to My Watchlist
What is My Watchlist?
